Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 2Unknown 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 14Gastrointestinal 8Thoracic 4Genitourinary 4Gynecologic 2CNS 2Tumor-Agnostic 1Sarcoma 1Other neoplasm 1Head & Neck 1

Conditions

Neuroblastoma 1Meningioma 1

Interventions

Temozolomide 299Radiotherapy 219Bevacizumab 139Carboplatin 91Cyclophosphamide 88Etoposide 82Filgrastim 72Vincristine 69Irinotecan 69Magnetic Resonance Spectroscopy 65Cisplatin 59Radiation 58Radiosurgery 52Surgical Procedures, Operative 41Peripheral Blood Stem Cell Transplantation 40Topotecan 39Doxorubicin 39Lomustine 37Carmustine 36sargramostim 35Granulocyte Colony-Stimulating Factor 35Melphalan 34Nivolumab 32Chemotherapy, Adjuvant 32Radiotherapy, Intensity-Modulated 29Isotretinoin 29Everolimus 29Erlotinib Hydrochloride 27Thiotepa 25Vorinostat 24

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Ropivacaine × CNS × Clear all
NCT02924324 2022-11-08

Local Injection of Pain Medication to Reduce Pain After Bone Marrow Procedures in Pediatric Neuroblastoma Patients

Memorial Sloan Kettering Cancer Center

Phase NA Completed
56 enrolled 8 charts
CNS

Neuroblastoma

NCT03648034 2020-04-06

Effects of Scalp Nerve Block With Ropivacaine on Postoperative Recovery Quality

RenJi Hospital

Phase NA Completed
144 enrolled
CNS

Meningioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡